Cargando…
Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
BACKGROUND AND AIM: Existing data are controversial regarding the incidence of hepatitis C (HCV)–related hepatocellular carcinoma (HCC) following directly acting antiviral (DAA) therapy. This prospective study aimed to assess incidence, and risk factorss of HCC following DAA therapy in patients with...
Autores principales: | Kilany, Shimaa, Ata, Lmyaa, Gomaa, Asmaa, Sabry, Aliaa, Nada, Ali, Tharwa, El-Sayed, Badra, Gamal, Abogabal, Ashraf, Elwaraky, Mohamed, Moaz, Enas, Ezzat, Sameera, Elsharawy, Ahmed, Waked, Imam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367200/ https://www.ncbi.nlm.nih.gov/pubmed/34408991 http://dx.doi.org/10.2147/JHC.S295330 |
Ejemplares similares
-
Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2020) -
Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
por: Gomaa, Asmaa Ibrahim, et al.
Publicado: (2014) -
Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis
por: Badra, Gamal, et al.
Publicado: (2006) -
Intermediate stage hepatocellular carcinoma: a summary review
por: Elshaarawy, Omar, et al.
Publicado: (2019) -
Hepatitis C infection in Egypt: prevalence, impact and management strategies
por: Gomaa, Asmaa, et al.
Publicado: (2017)